‘Pharma bro’ Shkreli under investigation, says US prison authority


by   |  VIEW 209
‘Pharma bro’ Shkreli under investigation, says US prison authority

On Friday, the 8th of March 2019, the US Bureau of Prisons said that they launched a probe on the conducts of Martin Shkreli, a former drug company executive, inside the prison, after a Wall Street Journal had reported earlier that he had still been aiding his old company using a contraband cellphone.

In a statement, the US Bureau of Prisons said on Friday (March 8th), “When there are allegations of misconduct, they are thoroughly investigated and appropriate action is taken if such allegations are proven true.

This allegation is currently under investigation”. According to the US Bureau of Prisons, possession of a contraband cellphone in a prison usually is considered to be a serious offense and a breach of prison’s legislation, which could potentially result in grave disciplinary measures such as being separated from the inmates and restricted visits.

The prison officials had also added that possessing a contraband cellphone in a prison could lead to criminal charges. According to the Journal report, Shkreli, 35, still held a substantial extent of influence over the drug company, Phoenixus AG, which he founded in February 2015, previously known as Turing Pharmaceuticals.

Nevertheless, Shkreli had been facing a seven-year prison sentence over allegations of defrauding investors in a previous company and had still been more than five and a half years away from release.